Aquestive Therapeutics, Inc. - 8-K Filing

Aquestive Therapeutics issues investor presentation detailing Anaphylm regulatory timelines and pipeline development. (Items: 7.01 by reference)

SEC EDGAR ·

Tickers: $AQST

Read the full article at SEC EDGAR

More Regulatory news